CDER chief Høeg expected to leave FDA, according to source

Tracy Beth Høeg, the head of the FDA's drug division, is anticipated to leave the agency following the recent resignation of Commissioner Marty Makary. This leadership change could have significant implications for the FDA's direction and decision-making in drug regulation.